• Letter Templates

  • Instructions:

    1. Select the template you would like to use, the click 'Let's Get Started'.

    2. Complete the fields on the next page with the information you would like to include in your letter.

    3. Once done, click 'Populate Template'.

    4. The template will appear with the information you submitted. Highlight the content, then copy and paste it into an email or into a Word document.

    5. Delete any of the dot points you don't want to use.

    6. Make any further changes based on your own personal circumstances. Delete any content you do not wish to include.

    7. Check and update any of the references that have been included. Although current at the time of being accessed (see associated footnote), the information may have changed. Information that is current and accurate is more likely to substantiate your correspondence.

    8. Proof-read and send.

    Note: no information is submitted or held by completing this form - it is only available whilst you have the form open. There is no provision to save and return to the form; once it is closed, the information will disappear.

  • Requesting an exemption template

  • The purpose of this template is to request a exemption from your employer (or organisation you are affiliated with), if they have indicated that they will consider exemptions.

  • Requesting information template

  • The purpose of this template is to request information from your employer (or organisation you are affiliated with), so you are better equipped to make an informed decisions about your circumstances.

    • Your information  
    • Information about the entity that the correspondence is going to  
    • Specific content for the template  

    • The next few questions will help construct the following sentence:

      I wish to seek an exemption from the [{whatHas33}] [{trigger}], dated [{dateOf}].

       

    • Some of the dot points in the letter/email refer to a policy and/or the reference to a government health order or direction. These dot points should be removed or adjusted when you customise your document.

  • Based on the information you have provided the {preferredFormat} version of the {chooseYour} has been generated. Copy the content beneath the line and paste it into the body of your document, then adjust before sending.

  • {date}

    To:

    		{entitysName}
    {contactPerson}, {positionHeld}
    cc: {additionalContact}, {positionHeld21}; {additionalContact23}, {positionHeld22}

    Dear {contactPerson25},

    Re: {subjectLine28}

    I wish to seek an exemption from the {whatHas33} {trigger}, dated {dateOf}.

  • {date}

    To:     {entitysName}
              {contactPerson}, {positionHeld}

     

    Dear {contactPerson25},

    Re: {subjectLine28}

    I wish to seek an exemption from the {whatHas33} {trigger}, dated {dateOf}.

  • Dear {contactPerson25},

    I wish to seek an exemption from the {whatHas33} {trigger}, dated {dateOf}.

  • My reasons for the request are as follows:

    • I am not a front-line worker: I do not have direct contact with patients, customers or persons who are not employed by the organisation.
    • I work from home and do not have direct contact with colleagues. I am able to conduct my work effectively through email, video-conferencing and phone calls.

  • I have numerous concerns about the medical procedure, including (but not limited to):

    • Current information is based on limited, short-term efficacy and safety data.
    • It does not prevent infection or transmission of the SARS-CoV-2 coronavirus.
    • The duration of protection is unknown, and may be as little as two weeks following the second dose[1].
    • The rate of adverse event notifications for Covid-19 “vaccines” are demonstrably higher than other vaccines – with 69,077 reports in the Therapeutic Goods Administration (TGA)’s Database of Adverse Event Notifications (DAEN) since 22 February 2021; accounting for more than 78% of the total 88,016 vaccine-related reports entered since 20 October 1972.[2]
    • The affect that Covid-19 “vaccines” will have on fertility and sterility is as yet unknown; and the TGA admits that “the data to support safety in pregnancy are inadequate at this stage.”[3]
    • From a religious perspective and from an ethical and moral standpoint, I am opposed to the use of aborted human foetuses in the development of Vaxzevria[4] and in the testing of the Pfizer and Moderna “vaccines”[5].
    • The procedure is effectively experimental - using Health Minister Greg Hunt’s own words – Australia is “engaged in the world's largest ever vaccination rollout and …. clinical trial”[6].

  • Ultimately, based on the reasons above (among others), I wish to seek an exemption from the {entitysName} {whatHas33}.

    Yours faithfully,
    {yourName90}
    {yourPositionrole}

  • [1] According to the Australian Public Assessment Reports: “In monkeys, antibodies declined 2 weeks after the second dose [of Spikevax], raising long-term immunity concerns.” APAR for Elasomeran - Therapeutic Goods Administration (Sponsored by Moderna Australia Pty Ltd), August 2021; https://www.tga.gov.au/sites/default/files/auspar-elasomeran.pdf and “Antibodies and T cells in monkeys declined quickly over 5 weeks after the second dose of [Comirnaty], raising concerns over long term immunity” APAR for BNT162b2 (mRNA) - Therapeutic Goods Administration (Sponsored by Pfizer Australia Pty Ltd), January 2021; https://www.tga.gov.au/sites/default/files/auspar-bnt162b2-mrna-210125.pdf

    [2] Database of Adverse Event Notifications – medicines, Therapeutic Goods Administration – data for the period 01/01/1971-12/10/2021, data retrieved 07 November 2021; https://www.tga.gov.au/database-adverse-event-notifications-daen

    [3] Australian Public Assessment Report for BNT162b2 (mRNA) - Therapeutic Goods Administration (Sponsored by Pfizer Australia Pty Ltd), January 2021; https://www.tga.gov.au/sites/default/files/auspar-bnt162b2-mrna-210125.pdf

    [4] Australian Product Information Vaxzevria® (previously COVID-19 Vaccine AstraZeneca) (ChAdOx1-S) solution for injection, date of revision 20 August 2021; https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2021-PI-01194-1

    [5] Sausage Making at FDA: How Human Cancer Cells Got Into Vaccines - Robert F. Kennedy, Jr., 10 December 2020; information accessed 19 September 2021; https://childrenshealthdefense.org/defender/fda-cancer-cells-in-vaccines

    [6] Doorstop interview about the COVID-19 vaccine rollout on 22 February 2021; https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/doorstop-interview-about-the-covid-19-vaccine-rollout-on-22-february-2021

  • {date}

    To:

    		{entitysName}
    {contactPerson}, {positionHeld}
    cc: {additionalContact}, {positionHeld21}; {additionalContact23}, {positionHeld22}

     

  • {date}

    To:

    		{entitysName}
    {contactPerson}, {positionHeld}

     

  • Dear {contactPerson25},

    I am seeking further information/clarification regarding {entitysName}'s position on COVID-19-related matters. My questions are listed below; if these could please be answered in writing.

    1. Would you please advise me on what lawful (legal) basis the {entitysName} mandate can be applied (as it infringes human rights and other legislation) and refer me to actual law that you can mandate someone to be forced into an experiment without their ability to say NO.

    2. The {entitysName} Policy particularly references the {whatIs} effective {whenIs}. The nature of which has an expiration date and is also subject to change. How is the {entitysName} policy subject to change or be revoked should the {whatIs} be revoked or replaced?

    3. Could you please provide me with a copy of {entitysName}'s policy (or equivalent document) relating to the collection of private health information?

    4. Could you please provide me with a copy of {entitysName}'s policy (or equivalent document) relating to ethics and code of conduct?

    5. Could you please provide me with a copy {entitysName}'s COVID-19 vaccination risk assessment for employees?

    6. The State Governments are now legislating to make employers responsible for any injures or death caused by this experimental inoculation which has been shown not to prevent transmission or infection from the SARS-CoV-2 coronavirus. If I am required to be vaccinated against COVID-19 to retain my employment with {entitysName}, what liability will {entitysName} accept should I be injured or die as a result of the procedure? Are you going to provide me with a written document that guarantees that I or my family will be indemnified as a result of any injury or death?

    I look forward to receiving your written reply/clarification on these matters.

    Kind Regards,
    {yourName90}
    {yourPositionrole}

  • Should be Empty: